Objectives. We evaluated the influence of the insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene on coronary plaque morphology and calcification in patients with angiographically documented coronary artery disease (CAD).
The insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene has been reported to be associated with myocardial infarction (1, 2) and, in some studies, with coronary artery disease (CAD) (3) (4) (5) . However, these results could not be confirmed in a large prospective trial (6) and in a case-control study (7) . A recent study in patients undergoing coronary angiography suggested that the ACE I/D polymorphism is not associated with CAD itself but was closely associated with the occurrence of myocardial infarction (8) . Possible reasons for the discrepancies between these studies may be selection bias in some studies (1) (2) (3) (4) 7, 8) and the different genetic backgrounds of the study populations. Another important reason for these discrepancies may be the use of invasive or noninvasive methods for the assessment of CAD (9) . Intravascular ultrasound (IVUS) is a new method for detecting coronary atherosclerosis; its use enables transmural, tomographic imaging of coronary arteries in humans in vivo. This method allows the characterization of coronary plaque composition, including calcium deposits, dense and loose fibrous tissue and intimal hyperplasia (10, 11) . IVUS is especially useful in detecting the extent of in situ coronary calcium (12) . In symptomatic patients with CAD, calcification detected on conventional fluoroscopy has been shown (13) to be associated with an elevated risk of coronary events, and this prognostic relevance of coronary calcification was independent of age and gender.
The purpose of the present study was to use IVUS imaging in human coronary arteries in vivo to analyze the association among plaque morphology, extent of calcification and the ACE I/D genotype in patients with severe CAD.
Methods
Patients. Between October 1994 and February 1996, a series of 146 patients who were scheduled to undergo percutaneous transluminal coronary angioplasty were studied with the use of preinterventional IVUS. Patients were selected from a cohort of 826 patients undergoing coronary angioplasty. Selection criteria were stable angina pectoris during adequate medication, absence of severe vessel tortuosity (no bend Ͼ90°a t the prestenotic, intrastenotic and post-stenotic lesion site) and a reference vessel diameter Ͼ2 mm on angiography. The patients had a mean age of 60.0 Ϯ 8.7 years (range 36 to 76); 116 were men, 30 women; and 86 had a history of myocardial infarction. The basic characteristics of the study cohort are provided in Table 1 . The study was approved by the local ethics committee, and written informed consent was obtained from each patient before the procedure. Ultrasound procedures. All patients underwent diagnostic coronary angiography and coronary intervention according to standard techniques. IVUS imaging was performed with a commercially available intracoronary 3.2F monorail catheter operating at 30 MHz (Cardiovascular Imaging Systems, Wiesbaden, Germany), accommodated by the 8F guiding catheter used for coronary angioplasty. Before the coronary angioplasty, the IVUS catheter was advanced through the lesion of interest; after it was positioned distal to this lesion, a slow, manual, continuous pullback was performed. The gain control settings were adjusted to provide an optimal dynamic range. The ultrasound examination was recorded on S-VHS videotape, and the target lesion was analyzed by two independent observers (A.A., K.R.K.) according to qualitative criteria.
Plaque composition was classified as (11-13) poorly echoreflective plaque if Ͼ80% of the plaque area was composed of tissue with an echogenicity less than or equal to that of the adventitia; highly echoreflective plaque if Ͼ80% of the plaque area was composed of tissue producing echoes brighter than that of the adventitia but without acoustic shadowing; and calcified plaque if the plaque involved bright echoes with acoustic shadowing Ͻ90°, 90°to 180°or Ͼ180°of the vessel wall circumference.
Laboratory methods. All blood samples were taken after the patients had fasted overnight. Plasma total cholesterol and triglyceride levels were measured by enzymatic methods (Boehringer-Mannheim Biochemica, Mannheim, Germany), and high density lipoprotein (HDL) cholesterol levels were determined after sodium phosphotungstate/magnesium chloride precipitation. Low density lipoprotein (LDL) cholesterol levels were calculated according to the Friedewald formula.
Genomic DNA was isolated and purified from whole blood (from tubes containing EDTA) with the use of QIAamp spin columns according to the manufacturer's instructions (QIAamp Blood Kit, QIAGEN GmbH, Hilden, Germany). ACE genotypes were assessed by PCR using the primer sequences and PCR cycling conditions as described previously (14) . The PCR fragments were separated on a horizontal 5% polyacrylamide gel by electrophoresis and visualized by staining with silver solution. All gels were read by two independent observers (M.P., P.C.). According to the absence or presence of the 287-base pair insertion in the PCR product, the patients were classified as homozygous DD, homozygous II or heterozygous ID. To prevent mistyping of ID as DD genotypes, a second PCR with an insertion-specific primer was performed with all samples classified as homozygous DD in the first PCR (14, 15 *No significant differences between groups, except for age, which is lower for ID than for DD or II (p Ͻ 0.05). Data presented are mean value Ϯ SD or number of patients, unless otherwise indicated. ACE ϭ angiotensin-converting enzyme; BMI ϭ body mass index; D ϭ deletion; DBP ϭ diastolic blood pressure; HDL-C ϭ high density lipoprotein cholesterol; Hx ϭ history; I ϭ insertion; LAD ϭ left anterior descending coronary artery; LCx ϭ left circumflex coronary artery; LDL-C ϭ low density lipoprotein cholesterol; MI ϭ myocardial infarction; RCA ϭ right coronary artery; SBP ϭ systolic blood pressure; TGs ϭ triglycerides; Total-C ϭ total cholesterol. and range for plasma triglyceride levels because of its skewed distribution. The mean values for the three groups (DD, ID and II) were compared by one-way analysis of variance or the Kruskal-Wallis test (plasma triglycerides). Categoric data were assessed using the likelihood ratio test. The analysis was also carried out by means of an explorative multiple logistic regression analysis to assess the independent role of the different factors possibly influencing lesion morphology, with the presence or absence of plaque calcification as dependent variable. For this analysis, the continuous variables age; body mass index; total plasma cholesterol level, HDL and LDL cholesterol levels; and triglyceride levels were each grouped in quartiles. In addition, for the ACE genotype, odds ratios were calculated as a measure of the association with the plaque calcification, with the effects of the D allele assumed to be additive (with scores of 0, 1 and 2 for the II, ID and DD genotypes, respectively), dominant (with scores of 0 for the II genotypes and 1 for the ID and DD genotypes) or recessive (with scores of 0 for the II and ID genotypes and 1 for the DD genotypes). For each odds ratio, the 95% confidence intervals and two-tailed p values were calculated. All analyses were done with use of a personal computer with JMP 3.2 (SAS Institute). A p value Ͻ0.05 was considered statistically significant.
Results
The (1, 7) and North America (6), and the distribution was consistent with the study population being in Hardy-Weinberg equilibrium. Thus, with respect to the ACE gene locus, our sample is representative of white populations. The genotype groups were well matched for gender, body mass index and smoker status. Age was significantly lower in the ID group than in the DD and II groups (p ϭ 0.02). Systolic and diastolic blood pressures did not differ among the groups, and there were no significant differences in plasma lipid and lipoprotein levels. The distribution of vessels examined did not differ among the genotype groups ( Because age and gender have been shown (16) to be the most important risk factors for coronary calcification detected by ultrafast computed tomography in asymptomatic men and women, multiple logistic regression analysis was performed to correct for these and other possible influencing factors. Age was found to be the strongest predictor of coronary plaque calcification (OR 6.03, 95% CI 1.87 to 21.47, p ϭ 0.003), whereas gender, hypertension and a history of smoking were not found to be predictive of plaque calcification (Table 3 ). In *Age, body mass index (BMI), total cholesterol (Total-C), high density lipoprotein (HDL-C) and low density lipoprotein (LDL-C) cholesterol and triglycerides (TGs) were grouped in quartiles. †Systolic blood pressure Ͼ140 mm Hg, diastolic blood pressure Ͼ90 mm Hg, or both, at repeated measurements or the current use of antihypertensive agents for a confirmed diagnosis of arterial hypertension. CI ϭ confidence interval; OR ϭ odds ratio; other abbreviations as in Table 1. addition to age, the ACE DD genotype again proved to be associated with coronary plaque calcification (OR 3.69, 95% CI 1.47 to 10.19, p ϭ 0.0049). There were also no significant relations between coronary plaque calcification and a history of myocardial infarction or plasma lipid and lipoprotein levels ( Table 3) .
The analysis of the odds ratios between the presence or absence of coronary plaque calcification and the three ACE genotypes, adjusted for age, revealed a recessive effect of the D allele with an adjusted OR of 2.62 in the model comparing the DD genotypes with the ID and II genotypes (95% CI 1.16 to 6.42, p ϭ 0.02). Using the model for an additive effect of the D allele, the adjusted odds ratio for the DD versus the ID genotype was 2.72 (95% CI 1.15 to 6.92, p ϭ 0.02); for the ID genotype versus the II genotype, the adjusted odds ratio was 0.88 (95% CI 0.35 to 2.18, p ϭ 0.79). In the model for the dominant effect of the D allele, the adjusted odds ratio was 1.28 (95% CI 0.53 to 3.00, p ϭ 0.58) for the DD and ID genotypes versus the II genotype.
Discussion
The results of the present study showed that the ACE DD genotype is associated with the incidence and extent of coronary calcification as assessed by IVUS. Although the major determinant of coronary plaque calcification is age, the association with the ACE DD genotype persists after correction for age and is stronger than the nonsignificant association between history of myocardial infarction and coronary plaque calcification.
IVUS and plaque calcification. The ability of IVUS to characterize coronary plaque composition and calcification is well documented (10 -12) . IVUS has been shown (17) to be highly sensitive and specific in detecting dense, coherent calcification in human coronary arteries compared with histologic examination and to be far more sensitive than angiography in the diagnosis of coronary calcification (12) . The improved characterization of coronary plaque morphology by IVUS examination led to the finding of an association of plaque calcification with the ACE gene D polymorphism, which was not detected by coronary angiography. This observation could explain why the ACE gene polymorphism seemed not to be associated with native CAD as determined by coronary angiography, but with myocardial infarction in some studies (2, 8) .
Plaque calcification and coronary events. One of the important findings of this study is the relatively low prevalence of noncalcified lesions. This result is compatible with those in a subgroup of patients with stable angina pectoris in a study (18) using IVUS to identify unstable coronary lesions. However, the inclusion of only patients with stable angina may be a selection bias in the cohort investigated. Although patients with severe coronary plaque calcification may be less prone to acute coronary events than are patients with unstable lesions, the frequency of stable lesions in patients who died abruptly of myocardial infarction has been shown (19) to be ϳ50%. In addition, the interface between a calcified region of coronary plaque and the adjacent noncalcified region seems to be exposed to increased mechanical shear stress, resulting in plaque disruption (20) . In agreement with these results, and in concordance with the currently accepted theory of plaque rupture, 59% of our patients had a history of myocardial infarction. The increased frequency of calcified lesions among patients with the ACE DD genotype could explain the recently described observation that the beneficial effects of lipidlowering therapy on ischemic events and angiographically defined coronary stenosis are blunted among patients with the ACE DD genotype (21) .
ACE polymorphism and plaque calcification. The significant association of the ACE D polymorphism with coronary plaque calcification is in accordance with the recent findings of Rasmussen and Cedet (22) , who described an increased extent of macroscopically visible aortic atherosclerosis at autopsy in both insulin-dependent and -independent diabetic patients who were homozygous or heterozygous for the ACE D allele. In that postmortem study, the ACE gene polymorphism was not related to total collagen and type IV or V collagen, indicating a possible involvement of the ACE gene polymorphism in the later stages of atherosclerosis.
In the past, coronary calcification has been regarded as a passive process of adsorption or precipitation of calcium phosphate crystals. Recently, coronary plaque calcification has been recognized as an organized, regulated process (23) . Coronary calcification is absent in the normal arterial vessel wall and seems to occur only late in the development in atherosclerotic lesions (24) . The influence of genetic factors on the occurrence of arterial calcification has recently been shown in genetically distinct inbred mice (25) . Although the molecular basis for the incorporation of calcium and the extent of this calcification is not completely understood, several proteins involved in bone formation and calcification have been identified in atherosclerotic human coronary artery specimens (26) . One of these proteins, osteopontin, a phosphorylated glycoprotein, has been shown (26) to be present at the calcification front of atherosclerotic segments, and osteopontin mRNA expression by macrophages has been demonstrated to be related to the severity of atherosclerosis (27) . In addition to basic fibroblast growth factor and transforming growth factorbeta, angiotensin II is known to increase the osteopontin mRNA and protein expression in vascular smooth muscle cells in vitro (28) . Both circulating (29) and local (30) cardiac activities of ACE are higher in the presence of the ACE gene D polymorphism, which might increase the conversion of the inactive angiotensin I to the highly active angiotensin II. Thus, it can be speculated that in addition to its documented role in vasoconstriction and vascular smooth muscle cell growth (31), the renin-angiotensin system may also be involved in the regulation of calcification in atherosclerotic arteries.
Study limitations. This study is limited by the possible selection bias due to the inclusion of only patients with stable angina and to the relatively low number of patients. The number of patients examined was too low to find or exclude associations between ACE I/D gene polymorphism and myocardial infarction, so the relation among ACE polymorphism, coronary plaque calcification and myocardial infarction remains somewhat speculative. In addition, the lack of association among the plasma lipids, hypertension and diabetes on the coronary plaque morphology must be interpreted with caution because the duration and modification of these risk factors were not known. Furthermore, the mechanisms by which the intronic ACE I/D polymorphism could influence coronary plaque calcification are hypothetic. Probably, the ACE I/D polymorphism is only a marker for the functional polymorphism or mutation that influences coronary plaque calcification, so the linkage disequilibrium between the two polymorphisms may be limited to the cohort examined. However, an association between the ACE I/D gene polymorphism and the carotid artery wall thickness has recently been reported (32) in an ethnically distinct group of Japanese patients with noninsulin-dependent diabetes mellitus, indicating an involvement of this ACE polymorphism in the development or progression of atherosclerosis in different populations and vessel regions.
Conclusions. The findings of the present study suggest that in addition to age, the ACE DD genotype is an independent determinant of the incidence and extent of coronary plaque calcification in patients with stable angina pectoris. This observation is a possible explanation for the increased risk of cardiovascular events in patients with CAD who have the ACE DD genotype.
